Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Related Articles by Review for PubMed (Select 14681205)

1.

The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Lewis BC, Klimstra DS, Varmus HE.

Genes Dev. 2003 Dec 15;17(24):3127-38. Epub 2003 Dec 17.

2.

Oncogenic co-operation in beta-cell tumorigenesis.

Pelengaris S, Khan M.

Endocr Relat Cancer. 2001 Dec;8(4):307-14. Review.

3.

Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.

Adsay NV, Basturk O, Cheng JD, Andea AA.

Semin Radiat Oncol. 2005 Oct;15(4):254-64. Review.

PMID:
16183479
4.
5.

Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Skoudy A, Hernández-Muñoz I, Navarro P.

J Gastrointest Cancer. 2011 Jun;42(2):76-84. doi: 10.1007/s12029-011-9258-0. Review.

PMID:
21279552
6.

The molecular genetics of pancreatic ductal carcinoma.

Sohn TA.

Minerva Chir. 2002 Oct;57(5):561-74. Review.

PMID:
12370658
7.

Transgenic mice expressing cholecystokinin 2 receptors in the pancreas.

Clerc P, Saillan-Barreau C, Desbois C, Pradayrol L, Fourmy D, Dufresne M.

Pharmacol Toxicol. 2002 Dec;91(6):321-6. Review.

PMID:
12688375
8.

Genetic abnormalities in pancreatic cancer.

Moore PS, Beghelli S, Zamboni G, Scarpa A.

Mol Cancer. 2003 Jan 7;2:7. Review.

9.

Development of a flexible and specific gene delivery system for production of murine tumor models.

Fisher GH, Orsulic S, Holland E, Hively WP, Li Y, Lewis BC, Williams BO, Varmus HE.

Oncogene. 1999 Sep 20;18(38):5253-60. Review.

10.

Molecular pathways in pancreatic carcinogenesis.

Macgregor-Das AM, Iacobuzio-Donahue CA.

J Surg Oncol. 2013 Jan;107(1):8-14. doi: 10.1002/jso.23213. Epub 2012 Jul 17. Review.

11.

Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases.

Pour PM, Sayed S, Sayed G.

Am J Clin Pathol. 1982 Feb;77(2):137-52. Review.

PMID:
7039298
12.

Recent results in animal models of pancreatic carcinoma: histogenesis of tumors.

Longnecker DS, Memoli V, Pettengill OS.

Yale J Biol Med. 1992 Sep-Oct;65(5):457-64; discussion 465-9. Review.

13.
14.

Modeling pancreatic cancer in vivo: from xenograft and carcinogen-induced systems to genetically engineered mice.

Ding Y, Cravero JD, Adrian K, Grippo P.

Pancreas. 2010 Apr;39(3):283-92. doi: 10.1097/MPA.0b013e3181c15619. Review.

PMID:
20335777
15.

[New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].

Esposito I, Konukiewitz B, Schlitter AM, Klöppel G.

Pathologe. 2012 Nov;33 Suppl 2:189-93. doi: 10.1007/s00292-012-1673-x. Review. German.

PMID:
23011021
16.

Genetic alterations in pancreatic carcinoma.

Schneider G, Schmid RM.

Mol Cancer. 2003 Jan 22;2:15. Review.

17.

Histopathologic assessment of pancreatic cancer: does one size fit all?

Reid MD, Bagci P, Adsay NV.

J Surg Oncol. 2013 Jan;107(1):67-77. doi: 10.1002/jso.23194. Epub 2012 Jun 18. Review.

PMID:
22711682
18.

Retrovirus-mediated oncogene transfer into neural transplants.

Wiestler OD, Brüstle O, Eibl RH, Radner H, Aguzzi A, Kleihues P.

Brain Pathol. 1992 Jan;2(1):47-59. Review.

PMID:
1341947
19.

Immortalisation and transformation revisited.

Drayton S, Peters G.

Curr Opin Genet Dev. 2002 Feb;12(1):98-104. Review.

PMID:
11790562
20.

Early detection of pancreatic carcinoma.

Rosty C, Goggins M.

Hematol Oncol Clin North Am. 2002 Feb;16(1):37-52. Review.

PMID:
12063828
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk